Christopher Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christopher Chan has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Adam Jaffe
School of Clinical Medicine, Discipline of Paediatrics and Child Health, University of New South Wales , Sydney
2 shared publications - Bernadette Prentice
Discipline of Paediatrics and Child Health, School of Clinical Medicine University of New South Wales Sydney Australia
2 shared publications - Caitlin Murphy
School of Clinical Medicine, Discipline of Paediatrics & Child Health, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia
2 shared publications - Chee Yee Ooi
Molecular and Integrative Cystic Fibrosis (miCF) Research Centre UNSW Sydney Sydney New South Wales Australia
2 shared publications - Hannah Wrigley-Carr
School of Clinical Medicine, Discipline of Paediatrics & Child Health, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia
2 shared publications - Isabelle McKay
School of Clinical Medicine, Discipline of Paediatrics & Child Health, UNSW Medicine & Health, University of New South Wales, Sydney, NSW 2031, Australia
2 shared publications
Latest Publications
- Open Access
- 18 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (3) , 681
The Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer but the pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is implicated in intestinal carcinogenesis via the production of colibactin; however, the relevance in CF is unknown. In this study, we investigate pks+E. coli prevalence in CF and potential associations between pks+E. coli, gastrointestinal inflammation, and microbiome dynamics with fecal calprotectin and 16SrRNA gene taxonomic data. Cross-sectional analysis demonstrated no difference in pks+E. coli carriage between CF patients and healthy controls, 21/55 (38%) vs. 26/55 (47%), p = 0.32. Pks+E. coli was not associated with significant differences in mean (SD) calprotectin concentration (124 (154) vs. 158 (268) mg/kg; p = 0.60), microbial richness (159 (76.5) vs. 147 (70.4); p = 0.50) or Shannon diversity index (2.78 (0.77) vs. 2.65 (0.74); p = 0.50) in CF. Additionally, there was no association with exocrine pancreatic status (p = 0.2) or overall antibiotic use (p = 0.6). Longitudinally, CF subjects demonstrated intra-individual variation in pks+E. coli presence but no significant difference in overall prevalence. Future investigation into the effects of repeat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- 18 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (3) , 681
Open AccessThe Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer but the pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is implicated in intestinal carcinogenesis via the production of colibactin; however, the relevance in CF is unknown. In this study, we investigate pks+E. coli prevalence in CF and potential associations between pks+E. coli, gastrointestinal inflammation, and microbiome dynamics with fecal calprotectin and 16SrRNA gene taxonomic data. Cross-sectional analysis demonstrated no difference in pks+E. coli carriage between CF patients and healthy controls, 21/55 (38%) vs. 26/55 (47%), p = 0.32. Pks+E. coli was not associated with significant differences in mean (SD) calprotectin concentration (124 (154) vs. 158 (268) mg/kg; p = 0.60), microbial richness (159 (76.5) vs. 147 (70.4); p = 0.50) or Shannon diversity index (2.78 (0.77) vs. 2.65 (0.74); p = 0.50) in CF. Additionally, there was no association with exocrine pancreatic status (p = 0.2) or overall antibiotic use (p = 0.6). Longitudinally, CF subjects demonstrated intra-individual variation in pks+E. coli presence but no significant difference in overall prevalence. Future investigation into the effects of repeat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- Open Access
- 13 February 2025
- Published by MDPI AG in Preprints.org
The Prevalence of pks+ E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- 13 February 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Prevalence of pks+ E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- Open Access
- 6 August 2024
- Published by Wiley in Pediatric Pulmonology
- Vol. 59 (S1) , S70-S80
The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis
People with cystic fibrosis (pwCF) have an altered gastrointestinal microbiome. These individuals also demonstrate propensity toward developing small intestinal bacterial overgrowth (SIBO). The dysbiosis present has intestinal and extraintestinal implications, including potential links with the higher rates of gastrointestinal malignancies described in CF. Given these implications, there is growing interest in therapeutic options for microbiome modulation. Alternative therapies, including probiotics and prebiotics, and current CF transmembrane conductance regulator gene modulators are promising interventions for ameliorating gut microbiome dysfunction in pwCF. This article will characterize and discuss the current state of knowledge and expert opinions on gut dysbiosis and SIBO in the context of CF, before reviewing the current evidence supporting gut microbial modulating therapies in CF.
- 6 August 2024
- Published by Wiley in Pediatric Pulmonology
- Vol. 59 (S1) , S70-S80
Open AccessThe gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis
People with cystic fibrosis (pwCF) have an altered gastrointestinal microbiome. These individuals also demonstrate propensity toward developing small intestinal bacterial overgrowth (SIBO). The dysbiosis present has intestinal and extraintestinal implications, including potential links with the higher rates of gastrointestinal malignancies described in CF. Given these implications, there is growing interest in therapeutic options for microbiome modulation. Alternative therapies, including probiotics and prebiotics, and current CF transmembrane conductance regulator gene modulators are promising interventions for ameliorating gut microbiome dysfunction in pwCF. This article will characterize and discuss the current state of knowledge and expert opinions on gut dysbiosis and SIBO in the context of CF, before reviewing the current evidence supporting gut microbial modulating therapies in CF.
- Open Access
- 5 October 2023
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (6) , 1032-1038
“We’re trained to trust our patients”: a qualitative study on the general practitioners’ trust in patients for colorectal cancer shared care
Background: In a therapeutic partnership, physicians rely on patients to describe their health conditions, join in shared decision-making, and engage with supported self-management activities. In shared care, the patient, primary care, and specialist services partner together using agreed processes and outputs for the patient to be placed at the centre of their care. However, few empirical studies have explored physicians’ trust in patients and its implications for shared care models. Aim: To explore trust in patients amongst general practitioners (GPs), and the impacts of trust on GPs’ willingness to engage in new models of care, such as colorectal cancer shared care. Methods: GP participants were recruited through professional networks for semi-structured interviews. Transcripts were integrity checked, coded inductively, and themes developed iteratively. Results: Twenty-five interviews were analysed. Some GPs view trust as a responsibility of the physician and have a high propensity for trusting patients. For other GPs, trust in patients is developed over successive consultations based on patient characteristics such as honesty, reliability, and proactivity in self-care. GPs were more willing to engage in colorectal cancer shared care with patients with whom they have a developed, trusting relationship. Conclusions: Trust plays a significant role in the patient’s access to shared care. The implementation of shared care should consider the relational dynamics between the patient and health care providers.
- 5 October 2023
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (6) , 1032-1038
Open Access“We’re trained to trust our patients”: a qualitative study on the general practitioners’ trust in patients for colorectal cancer shared care
Background: In a therapeutic partnership, physicians rely on patients to describe their health conditions, join in shared decision-making, and engage with supported self-management activities. In shared care, the patient, primary care, and specialist services partner together using agreed processes and outputs for the patient to be placed at the centre of their care. However, few empirical studies have explored physicians’ trust in patients and its implications for shared care models. Aim: To explore trust in patients amongst general practitioners (GPs), and the impacts of trust on GPs’ willingness to engage in new models of care, such as colorectal cancer shared care. Methods: GP participants were recruited through professional networks for semi-structured interviews. Transcripts were integrity checked, coded inductively, and themes developed iteratively. Results: Twenty-five interviews were analysed. Some GPs view trust as a responsibility of the physician and have a high propensity for trusting patients. For other GPs, trust in patients is developed over successive consultations based on patient characteristics such as honesty, reliability, and proactivity in self-care. GPs were more willing to engage in colorectal cancer shared care with patients with whom they have a developed, trusting relationship. Conclusions: Trust plays a significant role in the patient’s access to shared care. The implementation of shared care should consider the relational dynamics between the patient and health care providers.
- 1 April 2001
- Published by Emerald Publishing in Personnel Review
- Vol. 30 (2) , 227-239
Pressures and stress in a West Australian hospital
Using the Occupational Stress Indicator, the results from this study provided a comparative overview of Australian and UK hospital workers’ perceived responses to organizational sources of pressure, use of coping strategies plus outcomes of job satisfaction, mental and physical ill health. The broad picture that emerged was that the Australian hospital workers appeared to have a more favourable working environment as their organization presented fewer sources of pressure. Despite lower levels of contributory pressure, it was apparent that Australian hospital workers perceived similar long‐term outcomes to organizational sources of pressure as the UK hospital worker sample. The Australian hospital workers reported significantly higher perceived physical ill health, and second, similar levels of mental ill health and job satisfaction when compared to the UK hospital workers. In addition, the Australian hospital workers reported increased use of coping strategies. The discussion takes into consideration the context and time frame of the two operating environments.
- 1 April 2001
- Published by Emerald Publishing in Personnel Review
- Vol. 30 (2) , 227-239
Pressures and stress in a West Australian hospital
Using the Occupational Stress Indicator, the results from this study provided a comparative overview of Australian and UK hospital workers’ perceived responses to organizational sources of pressure, use of coping strategies plus outcomes of job satisfaction, mental and physical ill health. The broad picture that emerged was that the Australian hospital workers appeared to have a more favourable working environment as their organization presented fewer sources of pressure. Despite lower levels of contributory pressure, it was apparent that Australian hospital workers perceived similar long‐term outcomes to organizational sources of pressure as the UK hospital worker sample. The Australian hospital workers reported significantly higher perceived physical ill health, and second, similar levels of mental ill health and job satisfaction when compared to the UK hospital workers. In addition, the Australian hospital workers reported increased use of coping strategies. The discussion takes into consideration the context and time frame of the two operating environments.